THANK YOU FOR SUBSCRIBING
Pharma Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Pharma Tech Outlook
Jacob Lee, CEO and Co-Founder Born out of the pandemic, Genemod is driven by a goal to accelerate life sciences R&D by improving collaboration among teams in a hybrid workspace so that scientists can work on big ideas without the busywork. “The best unicorns are built out of recessions. We launched in 2020 after three years of development in stealth; the premise was to create a collaborative cloud-based platform, as the Atlassian for life scientists,” says Jacob Lee, CEO and Co-Founder of Genemod. The company has continuously scaled since its foundation, focusing on expanding access and usability for academic labs, small companies, and giant enterprise companies alike.
Genemod’s proprietary technology brings together both scientific and management tools onto a single, shared platform to help scientists streamline operations. Lee explains that life scientists and researchers working on the next life-saving breakthrough therapeutic or vaccine often leverage methodologies that are old school and archaic, utilizing siloed means of data sharing and traditional processes of recording and storing data. They do not find any possibility to use past data and experiments to inform future decision-making. “Our platform allows researchers to record, analyze, and intuitively visualize their projects and inventory in one place – something that has never been done before,” Lee comments. The company launched project management in 2021, allowing researchers to localize and execute their experiments to the web app, create protocol libraries, manage data files while offering users more collaboration options in a hybrid research lab environment.
What steers Genemod ahead of the market competition is its focus on offering robust and reliable tools for making pre-clinical research efficient, scalable, and reproducible for life scientists. “The best way to thwart market competition is to build a product that customers love. Rather than solely focusing on one field, we build products that touch upon various aspects under the life sciences R&D umbrella for scientists to simplify and streamline lab work,” notes Tina Lu, Founding Member and Designer at Genemod. Backed by a team of technology entrepreneurs and scientists, the company is flexible enough to prioritize and deliver exactly what researchers need.
Tina Lu, Visionary Educator and Strategic LeaderThis agility requires Genemod to focus on team well-being as well as drive a customerobsessive culture into the company based on hard data. Next to the hard data is the soft data: “the why.” The soft data is collected by interacting with customers, running hypotheses-focused experiments, and evaluating the feedback from customer support and surveys.
As a testament to the robust capabilities of Genemod’s platform, Lee recalls how Christopher Reid, an Associate Professor of Science and Technology at Bryant University, was able to save valuable time and energy locating data with Genemod. Reid and his team had run their chemistry research lab studying bacterial cell wall metabolism for more than a decade when they faced a new challenge; they lacked an effective method to manage large amounts of reagent data with different team members and storage locations. The freezers were documented on a single laptop that held a local copy of all the reagents—a local copy of decade-long research was dangerous and hard to manage. Only after spending a significant amount of time discovering his inventory could Reid delegate tasks to his staff to begin gathering materials. However, each team member also had to return to the laptop to find their own needed reagents. The lab needed a new inventory software package to save valuable time and energy by making it easier to store, search, and update data. Genemod solved all the key issues that Professor Reid faced by creating a cloud backup of the lab’s data on Amazon Web Services (AWS) to ensure security and dispersed access to freezers. Reid and his assistant could remotely access their inventory and prep and assign tasks ahead of time with improved upfront planning.
Genemod plans to integrate with marketleading products and tools which scientists are already using every day, such as Microsoft Teams and Slack, in the upcoming years. Alongside integrations, the company is also focusing on workflow management and reporting. Genemod intends to double down its efforts toward serving its customers worldwide. The company also continues to support scientists in the ongoing challenge to global health by partnering with multiple federal grants to help with COVID research. “This is something unique to us; we launched at the right time—the beginning of the pandemic. We can certainly leverage our resources and capabilities to this end. We also see an uptick in inventory and project management, as companies have started using Genemod as a collaborative tool across an entire organization rather than just within a team of scientists,” says Lee.
Our platform allows researchers to record, analyze, and intuitively visualize their projects and inventory in one place – something that has never been done before
Company
Genemod
Management
Jacob Lee, CEO and Co-Founder and Tina Lu, Visionary Educator and Strategic Leader
Description
Genemod has created a world-class cloud-based platform to maximize productivity in bench research and drive the next generation of therapies. Born out of the pandemic, the company is driven by a goal to accelerate life sciences R&D by improving collaboration among teams in a hybrid workspace so that scientists can work on big ideas without the busywork. Genemod’s proprietary technology brings together both scientific and management tools onto a single, shared platform to help scientists streamline operations. The company’s platform allows researchers to record, analyze, and intuitively visualize their projects and inventory in one place
Genemod In the world's continuous battle against cancer, research laboratories are at the forefront, deciphering the disease's complexities to find groundbreaking treatments. Central to this quest is the monumental task of managing vast amounts of data generated from cancer research. Herein lies the revolution brought about by Laboratory Information Management Systems (LIMS), which have become indispensable tools in the modern cancer research laboratory. This article explores the transformative impact of cancer research LIMS, detailing how they streamline operations, ensure compliance, and foster collaboration.
Streamlined Data Management
Cancer research generates an overwhelming amount of data, from genomic sequences to clinical outcomes. LIMS for cancer research simplifies this complexity by providing a centralized platform for data management. It automates the tracking, storage, and analysis of data, eliminating manual errors and redundancies. This not only enhances the accuracy of research findings but also significantly reduces the time researchers spend on data management, allowing them to focus more on analytical and discovery processes.
Moreover, LIMS enables the seamless integration of diverse data types, including omics data and radiology images. This integration is crucial for comprehensive cancer research, where understanding the interplay between various data sets can lead to breakthroughs in personalized medicine.
Ensuring Compliance and Data Privacy
Cancer research laboratories must navigate a labyrinth of regulatory requirements, from HIPAA to IRB protocols. LIMS for cancer research is designed with built-in compliance features that automate the documentation and validation processes, ensuring that laboratories adhere to the latest regulations without cumbersome manual oversight. This includes managing patient consent forms, maintaining secure audit trails, and enforcing data access controls to protect patient privacy.
The importance of data privacy cannot be overstated in cancer research, where sensitive patient information is frequently handled. LIMS fortifies data security with advanced encryption and user authentication mechanisms, safeguarding against unauthorized access and ensuring that patient information remains confidential.
Fostering Collaboration and Data Sharing
The fight against cancer is a collective effort, requiring collaboration across different research teams and institutions. LIMS for cancer research facilitates this collaboration by enabling secure data sharing and communication within and between laboratories. Researchers can easily access and share datasets, findings, and resources in real time, speeding up the research process and fostering a collaborative environment that is conducive to innovation.
This collaborative capability is particularly beneficial for multi-institutional research projects and consortiums focused on cancer research. It ensures that all parties have access to the latest data and can contribute to and benefit from collective insights, accelerating the path to discovery.
Advancing Personalized Medicine
Personalized medicine is at the forefront of cancer treatment, tailoring therapies to the individual genetic makeup of a patient's tumor. LIMS plays a pivotal role in this area by managing the complex datasets required for genomic and biomarker analysis. It allows for the efficient categorization and retrieval of genetic information, enabling researchers to identify patterns and correlations that can inform personalized treatment strategies.
The ability to quickly analyze and interpret genetic data can dramatically shorten the time from diagnosis to treatment. LIMS for cancer research provides the technological backbone needed to leverage genomic data effectively, paving the way for more targeted and effective cancer therapies.
Scalability and Future-Proofing
As cancer research advances, laboratories must be able to adapt to new technologies and increasing data volumes. LIMS for cancer research offers scalable solutions that can grow with the laboratory, accommodating new data types, analysis methods, and research techniques. This scalability ensures that laboratories can remain at the cutting edge of cancer research, ready to incorporate the latest scientific advancements.
Furthermore, cloud-based LIMS options provide additional flexibility and accessibility, allowing researchers to access data and conduct analyses from any location. This is especially important in today’s global research environment, where collaboration often spans continents.
Accelerated Discovery through Automation
Automation of laboratory workflows is another significant advantage offered by LIMS in cancer research. By automating routine tasks such as sample tracking, data entry, and experimental workflows, LIMS significantly reduces the potential for human error and increases the efficiency of research operations. This automation not only ensures the reliability of data but also accelerates the pace of discovery, bringing us closer to finding effective cancer treatments faster.
Choosing Genemod to Revolutionize Cancer Research
In the dynamic landscape of cancer research, laboratories require robust, flexible, and compliant data management solutions. Genemod recognizes the unique challenges faced by cancer research laboratories and offers a specialized LIMS designed to meet these needs. Our LIMS for cancer research streamlines data management, ensures compliance, fosters collaboration, and supports the advancement of personalized medicine.
With Genemod’s LIMS, cancer research laboratories can focus on what they do best—driving innovations that improve patient outcomes. Discover how partnering with Genemod can revolutionize your cancer research operations and accelerate your journey towards groundbreaking discoveries.